Literature DB >> 18196972

Regulation of the p14ARF promoter by DNA methylation.

Vinay Badal1, Sergio Menendez, David Coomber, David P Lane.   

Abstract

The INK4a/ARF locus encodes p14(ARF) which plays an important role in the p53 pathway. Interestingly, methylation of the INK4a/ARF locus is a common event in carcinogenesis. In this study we analyzed the effect of epigenetic alteration on the p14(ARF) promoter and its direct link to the expression of the p14(ARF) mRNA and protein. The osteosarcoma cell line U2OS was used as a model to study the regulation of the ARF promoter by DNA methylation. Treatment of U2OS cells with the demethylating agent 5-aza- 2'-deoxycytidine (5-aza-CdR) showed a marked induction of the p14(ARF) mRNA and protein. A novel quantitative method described here, using restriction enzyme digestion followed by real time PCR, allowed the analysis of the level of methylation over a defined region of DNA on the p14(ARF) promoter. The change in the methylation level of the promoter closely corresponded to the increase in the transcription of p14(ARF) mRNA and protein. Upon removal of 5-aza-CdR the methylation pattern on the p14(ARF) promoter was re-laid with a concomitant decrease in the levels of p14(ARF) mRNA and protein. The increase in the levels of p14(ARF) was concomitant with an induction of G(1)-G(2) cell cycle arrest and an induction of p21 protein. No increase in the levels of p53 was observed. However, induction of p14(ARF) upon treatment with 5-aza-CdR led to the sequestering of MDM2 to the nucleolus. Additionally, we could show a dependency between the demethylation of the p14(ARF) promoter, the induction of p14(ARF) mRNA and protein and the effect of 5-aza-CdR on cell cycle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18196972     DOI: 10.4161/cc.7.1.5137

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  13 in total

1.  Altered DNA methylation profile in idiopathic pulmonary fibrosis.

Authors:  Yan Y Sanders; Namasivayam Ambalavanan; Brian Halloran; Xiangyu Zhang; Hui Liu; David K Crossman; Molly Bray; Kui Zhang; Victor J Thannickal; James S Hagood
Journal:  Am J Respir Crit Care Med       Date:  2012-06-14       Impact factor: 21.405

Review 2.  Epigenetic alterations in osteosarcoma: promising targets.

Authors:  Binghao Li; Zhaoming Ye
Journal:  Mol Biol Rep       Date:  2014-02-06       Impact factor: 2.316

3.  Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.

Authors:  Zsofia Turi; Marketa Senkyrikova; Martin Mistrik; Jiri Bartek; Pavel Moudry
Journal:  Cell Cycle       Date:  2017-12-10       Impact factor: 4.534

4.  Hypermethylation-mediated silencing of p14(ARF) in fibroblasts from idiopathic pulmonary fibrosis.

Authors:  José Cisneros; James Hagood; Marco Checa; Blanca Ortiz-Quintero; Miguel Negreros; Iliana Herrera; Carlos Ramos; Annie Pardo; Moisés Selman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-15       Impact factor: 5.464

5.  Promoter hypermethylation of tumour suppressor genes (p14/ARF and p16/INK4a): case-control study in North Indian population.

Authors:  Marjan Askari; Ranbir Chander Sobti; Mohsen Nikbakht; Suresh C Sharma
Journal:  Mol Biol Rep       Date:  2013-05-28       Impact factor: 2.316

Review 6.  Targeting prostate cancer based on signal transduction and cell cycle pathways.

Authors:  John T Lee; Brian D Lehmann; David M Terrian; William H Chappell; Franca Stivala; Massimo Libra; Alberto M Martelli; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

Review 7.  Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

Authors:  James J Morrow; Chand Khanna
Journal:  Crit Rev Oncog       Date:  2015

8.  MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma.

Authors:  Yingnan Sun; Shourong Shen; Xiaoping Liu; Hailin Tang; Zeyou Wang; Zhibin Yu; Xiayu Li; Minghua Wu
Journal:  Mol Cell Biochem       Date:  2014-01-10       Impact factor: 3.396

9.  Identification and functional characterization of FMN2, a regulator of the cyclin-dependent kinase inhibitor p21.

Authors:  Kayo Yamada; Motoharu Ono; Neil D Perkins; Sonia Rocha; Angus I Lamond
Journal:  Mol Cell       Date:  2013-01-31       Impact factor: 17.970

10.  Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.

Authors:  James Blackburn; Daniel L Roden; Robert Ng; Jianmin Wu; Alexis Bosman; Richard J Epstein
Journal:  Mol Carcinog       Date:  2015-12-16       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.